Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Myriad Genetics Inc (MYGN)

Myriad Genetics Inc (MYGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing GlobeNewswire - Mon Nov 4, 7:39AM CST

MYGN : 17.83 (-0.89%)
Myriad Genetics to Release Third Quarter 2024 Financial Results on November 7, 2024 GlobeNewswire - Wed Oct 30, 7:00AM CDT

MYGN : 17.83 (-0.89%)
Myriad Genetics and jscreen™ Announce Strategic Partnership to Advance Health Equity and Genetic Testing Access GlobeNewswire - Wed Oct 16, 8:00AM CDT

MYGN : 17.83 (-0.89%)
Myriad Genetics and Flatiron Health Partner to Make Genetic Testing More Accessible with Electronic Medical Record Integration GlobeNewswire - Tue Oct 15, 8:00AM CDT

MYGN : 17.83 (-0.89%)
Myriad Genetics Announces Five Research Collaborations to Study the Use of MRD Testing in Breast Cancer GlobeNewswire - Tue Oct 8, 3:05PM CDT

MYGN : 17.83 (-0.89%)
Myriad Genetics and Ultima Genomics to Explore the UG 100™ Sequencing Platform to Advance Clinical Test Offerings in Oncology and Reproductive Genomics GlobeNewswire - Thu Oct 3, 8:00AM CDT

MYGN : 17.83 (-0.89%)
Myriad: Q2 Earnings Snapshot AP - Tue Aug 6, 4:28PM CDT

Myriad: Q2 Earnings Snapshot

MYGN : 17.83 (-0.89%)
Myriad: Q1 Earnings Snapshot AP - Tue May 7, 3:47PM CDT

Myriad: Q1 Earnings Snapshot

MYGN : 17.83 (-0.89%)
Myriad: Q4 Earnings Snapshot AP - Tue Feb 27, 4:26PM CST

Myriad: Q4 Earnings Snapshot

MYGN : 17.83 (-0.89%)
Myriad: Q3 Earnings Snapshot AP - Mon Nov 6, 2023

Myriad: Q3 Earnings Snapshot

MYGN : 17.83 (-0.89%)

Barchart Exclusives

Is This High-Yield Dividend Stock a Buy After Earnings? Barchart - 37 minutes ago
This pharmaceutical giant's Q3 numbers came in ahead of Street estimates. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot